GlassScriptPhysician profile
Emily Lb Landrum
NPI 1639550783
$631.96
in general payments reported to CMS, 2019-2025
13 companies · $35.67 in 2025
The $35.67 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.60 · 2020: $47.22 · 2021: $99.20 · 2022: $35.57 · 2023: $35.36 · 2024: $282 · 2025: $35.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $309.67 | 2019-2025 | Evenity, Prolia |
| Edwards Lifesciences Corporation | $81.18 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Organon LLC | $54.49 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $31.38 | 2019-2023 | Imfinzi |
| Dexcom, INC. | $21.07 | 2025 | Dexcom G6 Transmitter |
| Sanofi Pasteur INC. | $20.46 | 2020 | |
| Tactile Systems Technology INC | $20.38 | 2021 | |
| Pfizer INC. | $20.24 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.80 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.47 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $14.69 | 2021 | |
| Glaxosmithkline, LLC. | $12.98 | 2020 | |
| Lilly USA, LLC | $12.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Landrum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.